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Os autores descrevem um caso de uma neoplasia pulmo-
nar rara – hemangioendotelioma epitelióide – numa 
doente do sexo feminino, de 39 anos, assintomática até 
Dezembro de 2003, altura em que apresentou toracalgia 
direita de características pleuríticas. A doente era porta-
dora de uma radiografia torácica antiga, efectuada há 13 
anos, que revelava múltiplos pequenos nódulos pulmo-
nares bilaterais, atribuídos a sequelas de tuberculose pul-
monar. O diagnóstico histológico definitivo foi efectua-
do através de biópsia pulmonar por toracotomia. Dado 
Abstract
The authors report a case of a rare pulmonary neo-
plasm – epithelioid hemangioendothelioma, in a 
39 year-old woman, asymptomatic until December 
2003, when she developed pleuritic and right-sided 
chest pain. The patient presented a previous chest ra-
diograph, performed 13 years before, which showed 
multiple small bilateral pulmonary nodules attribu-
ted to tuberculous sequelae. The definitive histologi-
cal diagnosis was made by lung biopsy through tho-
racotomy. The patient developed a clinical and 
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a doente ter apresentado agravamento clínico e imagio-
lógico foi iniciada terapêutica com interferão α-2a. Ape-
sar da estabilidade imagiológica das lesões pulmonares, a 
doente manteve-se sintomática e faleceu nove meses de-
pois do diagnóstico ter sido estabelecido.
Os autores realçam a raridade deste tipo de neoplasia 
pulmonar e discutem a sua apresentação clínica, ca-
racterísticas histológicas, tratamento e prognóstico. 
Rev Port Pneumol 2008; XIV (3): 421-425
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mão, interferão α.
imagiological worsening and then therapy with inter-
feron α-2a was started. Even with imagiological sta-
bility of pulmonary lesions the patient remained 
symptomatic and died nine months after the diagno-
sis had been established. 
The authors emphasise the rarity of this type of pul-
monary neoplasm and discuss its clinical presenta-
tion, histological features, treatment and prognosis.
Rev Port Pneumol 2008; XIV (3): 421-425
Key-words: Epithelioid hemangioendothelioma, lung, 
interferon α.
Introduction
Epithelioid hemangioendothelioma (EHE) 
is a rare pulmonary neoplasm, which was 
originally described in 1975 as intravascular 
bronchioloalveolar tumor (IVBAT). It is 
considered a low-grade sclerosing angiosar-
coma, can be multifocal as multiorganic 
and has metastic potential.
Clinical course is uncertain: sometimes 
there is slow growing of the lesions, but a 
rapid course can also occur with death within 
few months after the diagnosis. 
Case report
A 39-year-old nonsmoker woman, with a 
good global health status, developed pleu-
ritic, right-sided postero-inferior chest pain 
in December 2003, with no other com-
plaints. She took anti-inflammatory medi-
cation with no clinical improvement. The 
patient had no history of occupational or 
ambiental exposure to dusts, pets or birds, 
nor exposure to tuberculosis or recent travel 
outside the country. Her past medical his-
tory was unremarkable and she only took a 
contraceptive regularly. On physical exami-
nation, she had no cyanosis, clubbing, nor 
peripherical lymphadenopathy. Respiratory 
sounds were diminished at the right pulmo-
nary base and inspiratory crackles were au-
dible diffusely. A previous chest radiograph 
(1991) showed multiple bilateral pulmonary 
nodules, attributed to tuberculous sequelae, 
because of the high incidence of tuberculo-
sis in Portugal, although she had no known 
history of this disease. Actual chest radio-
graph showed increased number and size of 
the nodules and right pleural effusion. 
Pulmonary function tests showed a restric-
tive pattern – vital capacity: 2.13 L (59% of 
predicted); total lung capacity: 3.63 L (68% 
of predicted); residual volume: 1.50 L (90% 
of predicted); forced expiratory volume in 
one second (FEV1): 1.86 L (61% of pre-
dicted); forced vital capacity (FVC): 2.13 L 
(60% of predicted); FEV1/FVC: 87% – 
with decreased diffusion capacity of the 
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lung for carbon monoxide (16.4 mL/
mmHg/min; 60% of predicted). Full blood 
count, urea and electrolytes, liver function 
tests and calcium level were all normal. The 
erythrocyte sedimentation rate was 73 mm 
in the first hour and reactive C protein was 
2.2 mg/dl (normal value: < 0,8 mg/dl). Au-
toantibodies screen, including rheumatoid 
factor and antinuclear factor were negative. 
Tumor markers were normal, namely, carci-
no-embryonic antigen (CEA) – 1,7 ηg/ml 
(reference value: 0-3 ηg/ml) and cancer an-
tigen 125 (CA 125) – 14 U/ml (reference 
value: 0-35 U/ml).
Thoracic computed tomography (CT) scan 
confirmed multiple bilateral pulmonary 
nodules, approximately 1 cm or less in dia-
meter, ill-defined, non-calcified, with low-
density, scattered through the lungs, pre-
dominantly in the peripherical region and 
right-sided pleural effusion. There were also 
subpleural and peripherical linear opacities, 
suggesting interstitial component; neither 
hilar nor mediastinal lymphadenopathy 
were seen (Fig. 1). 
Right-sided thoracentesis revealed an exu-
date, with normal ADA (33 U/L), reactive 
mesothelial cells, some neutrophils and eo-
sinophils and no malignant cells. Fluid cul-
ture was negative. No endobronchial lesions 
were found at fiberoptic bronchoscopy and 
transbronchial lung biopsy revealed only in-
flammatory infiltrate in the interstitium. 
The bronchoalveolar lavage had a large 
number of macrophages (99%) and was 
negative for malignant cells and so was the 
microbiological analysis for Mycobacterium 
tuberculosis and fungi. 
The patient underwent a diagnostic thora-
cotomy in order to obtain a definitive histo-
logical diagnosis. 
Histologically the nodules had central fibri-
mixoid stroma, sometimes with a chondroid 
phenotype. The periphery of the nodules 
was more cellular with moderate nuclear 
atypia and low mitotic index. The cells had 
prominent cytoplasmatic vacuoles or intra-
cytoplasmatic lumina. Multifocal pleural 
involvement was documented and foci of 
vasculitis lesions were seen (Figs. 2 and 3). 
Immunohistochemical stains revealed posi-
tivity in the tumor cells for endothelial 
markers (CD31 and CD34) and negativity 
for S100 and CAM5.2, supporting the 
diagnosis of EHE (Fig. 4). 
There were no complications detected in 
post-operative period, and discharge hap-
penend 3 days after thoracotomy. The pa-
tient maintained pleuritic right-sided chest 
pain which was relieved by non-opiate cen-
tral analgesics.
Seven months after the onset of pulmonary 
symptoms she presented clinical deteriora-
Fig. 1 – Thoracic computed tomography scan: presence of multiple 
bilateral pulmonary nodules, approximately 1 cm or less in diame-
ter, ill-defi ned, non-calcifi ed, with low-density, scattered throughout 
the lungs, predominantly in the peripherical region, and a right-si-
ded pleural effusion; no hilar or mediastinal lymphadenopathy were 
seen.
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tion with increasing chest pain, requiring 
opiate analgesics and intercostal neural 
block. A simultaneous imagiological wor-
sening was documented, with right-sided 
pleural effusion of greater vo lume. So the-
rapy with interferon α-2a, 3 million units 
three times weekly was started. During 
four months under this treatment and with 
analgesic therapeutic, the patient remained 
clinically stable. Nevertheless, besides all 
these therapeutic strategies, there was cli-
nical worsening with uncontrolled chest 
pain, while thoracic CT scan did not show 
disease’s progression. Neither distant me-
tastasis nor respiratory failure were docu-
mented. Oral steroid (prednisolone 20 mg, 
per day) was empirically added, but the pa-
tient’s condition deteriorated further and 
occured sudden death at home, approxi-
mately thirteen months after the onset of 
symptoms. Since the patient had a diagno-
sis of malignancy, which was under these 
circumstances the possible cause of death, 
autopsy was not requested and the exact 
cause of death was not determined.
Discussion
EHE is a low-to-intermediate grade vascu-
lar tumor1. Involvement of the lungs is rare 
with only 50 cases described in the litera-
ture to the best of our knowledge2.
Most of patients are females, about 40% of 
them under 30 years.
The most common presentation is bilateral 
multiple nodular opacities on chest radio-
graph, up to 2 cm in diameter but most are 
less than 1 cm. In some cases there is exten-
Fig. 2 – Tumor nodules showing increased cellularity and fi brimi-
xoid stroma
Fig. 3 – The cells have prominent cytoplasmatic vacuoles or intra-
cytoplasmatic lumina
Fig. 4 – CD 34 stain: tumor cells stain positively
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sive calcification of the nodules and variable 
interstitial involvement. Patients are usually 
asymptomatic or have minor symptoms at 
the time of diagnosis. Chest pain, cough 
and sputum are common non-specific 
symptoms. About 10% of patients have 
pleural effusions. 
The tumour nodules are round to oval 
shaped with a typically hypocellular core 
with coagulative necrosis, hyalinization and 
calcification while the periphery is hypercel-
lular. The cytoplasm is abundant and intra-
cellular vacuoles are common, sometimes 
creating a signet-ring appearance, which 
suggests an attempt to form unicellular vas-
cular channels. The disease may invade the 
wall and lumen of small pulmonary arteries, 
veins and lymphatics. The immunohisto-
chemical study of our patient showed im-
munoreactivity of the neoplastic cells for 
CD31 and CD34, confirming its vascular 
nature, as currently described.
Diagnosis is usually made by open lung 
biopsy although there is one case in the lit-
erature in which transbronchial lung biopsy 
was sufficient to make the diagnosis2.
Because of the small number of patients with 
confirmed epithelioid hemangioendothelio-
ma, it is difficult to establish prognostic fac-
tors. The manifestation of respiratory symp-
toms at presentation, liver involvement, 
peripheral lymphadenopathy, spindle tu-
mour cells at histology, fibrous pleuritis with 
extrapleural proliferation and pleural effu-
sion on chest radiograph are associated with 
an unfavourable prognosis3.
Because of its rarity, there is no standard 
treatment. Surgery remains the preferable 
choice whenever there is a solitary nodule or 
a limited number of lesions. Three sponta-
neous partial regressions and a complete re-
sponse to carboplatin plus etoposide che-
motherapy have been described3,4.
The use of interferonα is a reliable possibility 
as it can induce partial remission5. EHE has a 
vascular origin with endothelial cell migra-
tion and proliferation induced by the fibrob-
last growth factor (FGF). Interferon α-2a is a 
potent angiogenesis inhibitor and it is be-
lieved that acts by blocking the action of 
FGF. However, the role of immunotherapy is 
not established2. The exact role of steroid in 
the tumor’s pathogenesis is not known. 
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